|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Intracellular Th Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... clinical trials: one to evaluate lumateperone as a monotherapy and the other ... to evaluate lumateperone as an adjunctive therapy with lithium or ... initiated Phase III development of lumateperone for the treatment of agitation ... Global Lumateperone Market Growth 2025-2031 ... . United States market for Lumateperone is estimated to increase from US$ million in ... analysis in US$ millions of the world Lumateperone industry. This Insight Report ... unique position in an accelerating global Lumateperone market. This Insight Report ... 2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... ), IMM-124E, cannabidiol , ITI-007 (lumateperon), JNJ-5279, Melatonin, bumetanide, OPN ... 2020 Insomnia (Sleep Deprivation) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... ), EVT201, lorediplon, nemorexant, IMB-115, lumateperone, JNJ-48816274, seltorexant (JNJ-42847922 ... Schizophrenia - Market Insights, Epidemiology and Market Forecast - 2030 ... America Pharmaceutical/ Lundbeck), Caplyta (lumateperone/ ITI-007, Intra-Cellular ... the sensor, Otsuka Pharmaceutical), Caplyta (lumateperone, Intra-Cellular Therapies), Secuado ( ... Fast Track Designation for lumateperone for the treatment of schizophrenia. ... Bipolar Depression – Pipeline Insight, 2020 ... Emerging Drugs Lumateperone: Intra-Cellular Therapies Lumateperone is a butyrophenone atypical ... size = 0.46). In both trials, lumateperone demonstrated a favorable safety profile ... Key Products Lurasidone Vortioxetine Lumateperone JNJ-18038683 Cariprazine ... Global Bipolar Disorder Industry Research Report 2020, Forecast to 2025 ... (Clozaril) It can be also divided by applications: lumateperone Central Nervous System (CNS) Disorders ... Global Bipolar Disorder Market Insight 2020, Forecast to 2025 ... (Clozaril) It can be also divided by applications: lumateperone Central Nervous System (CNS) Disorders ... Global Bipolar Disorder Therapeutics Drugs Market Growth 2024-2030 ... (Geodon) Clozapine (Clozaril) Segmentation by application lumateperone Central Nervous System (CNS) Disorders ... Global Bipolar Disorder Therapeutics Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... with a CAGR of % during review period. lumateperone accounting for % of the Bipolar Disorder ... segment by Application can be divided into lumateperone Central Nervous System (CNS) Disorders ... Global Bipolar Disorder Therapeutics Drugs Market Report 2020 ... (Abilify) Ziprasidone (Geodon) Industry Segmentation lumateperone Central Nervous System (CNS) Disorders ... COVID-19 Impact on Global Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2026 ... Therapeutics Drugs market is segmented into lumateperone Central Nervous System (CNS) Disorders ... Global Bipolar Disorder Therapeutics Drugs Market Status, Trends and COVID-19 Impact Report 2021 ... (Geodon)/Clozapine (Clozaril) Application Segmentation lumateperone Central Nervous System (CNS) Disorders ... Bipolar Disorder Therapeutics Drugs Market, Global Outlook and Forecast 2022-2028 ... Market Segment Percentages, by Application, 2021 (%) lumateperone Central Nervous System (CNS) Disorders ... Schizophrenia: Disease Inights and Market Forecasts to 2024 Delivery time for this report is 5 days “Schizophrenia: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Schizophrenia disease in the US, EU5 (Germany, France, ... Schizophrenia: Pipeline Assessment and Insights Delivery time for this report is 2-3 days “Schizophrenia: Pipeline Assessment and Insights” report delivers an in-depth understanding of the disease, highlights all the pipeline products in different phases of development for the disease including the ... Global Frontotemporal Disorders Treatment Market Size study & Forecast, by Drug Class (Cognitive Enhancers, Antipsychotics, Antidepressants, CNS Stimulants, Other Drug Classes), By Disease Indication (Frontotemporal Dementia, Primary Progressive Aphasia, Movement Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Analysis, 2023-2030 ... 2021, the US FDA authorized Caplyta (lumateperone) for the treatment of adult bipolar ... Schizophrenia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type ... palmitate aripiprazole lauroxil olanzapine cariprazine lumateperone lurasidone Others Companies Covered: Otsuka ... Atypical Antipsychotic Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type ... palmitate aripiprazole lauroxil olanzapine cariprazine lumateperone lurasidone Others Companies Covered: Otsuka ... Schizophrenia Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type ... palmitate aripiprazole lauroxil olanzapine cariprazine lumateperone lurasidone Others Companies Covered: Otsuka ... |